| Particulars |
| Company Name |
Jagsonpal Pharmaceuticals Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
13.38 |
B.V. Rs |
37.80 |
| Sales Rs Cr. |
268.72 |
NP Rs Cr. |
39.70 |
| NP Var% |
77.00 |
Div% |
125.00 |
| CPS Rs |
7.20 |
EPS Rs |
5.90 |
| Traded Value(Rs Lakhs) |
8.43 |
52 Week High |
302.00 |
| 52 Week Low |
155.00 |
Price BSE |
169.00 |
| Price NSE |
169.00 |
Market Capital(Rs Cr.) |
1,131.45 |
| P/C Ratio |
23.60 |
P/E Ratio |
28.50 |
| Price Vs.BV |
4.47 |
|
| Latest Quarter |
| Year End |
202512 |
Sales Rs Cr. |
72.95 |
| NP Rs Cr. |
12.49 |
NP Var % |
-8.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
226.85 |
| OPM |
13.93 |
NP |
26.76 |
| NP Var% |
16.92 |
EPS |
6.37 |
| PE |
26.55 |
|
|